Reply to the letter by L. Czako et al. regarding "Endoscopic submucosal dissection as a treatment for gastric noninvasive neoplasia : a multicenter study by Osaka University ESD Study Group"
スポンサーリンク
概要
- 論文の詳細を見る
- 2012-03-01
著者
-
Takehara Tetsuo
Department Of Gastroenterology And Hepatology (k1) Osaka University Graduate School Of Medicine
-
Nishida Tsutomu
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Kato Motohiko
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
TAKEHARA Tetsuo
Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine
-
Kato Motohiko
Department of Chemistry, Faculty of Engineering, Gunma University
関連論文
- Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts
- Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance
- Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization
- Factors contributing to antiviral effect of adefovir dipivoxil therapy added to ongoing lamivudine treatment in patients with lamivudine-resistant chronic hepatitis B
- Effect of interferon α-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis
- Serum levels of soluble major histocompatibility complex (MHC) class I-related chain A in patients with chronic liver diseases and changes during transcatheter arterial embolization for hepatocellular carcinoma
- Early emergence of entecavir-resistant hepatitis B virus in a patient with hepatitis B virus/human immunodeficiency virus coinfection
- Initial viral response is the most powerful predictor of the emergence of YMDD mutant virus in chronic hepatitis B patients treated with lamivudine
- Early decline of hemoglobin can predict progression of hemolytic anemia during pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C
- Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C